Axq Capital, LP Innoviva, Inc. Transaction History

Axq Capital, LP

$261 Billion
Q3 2025

A detailed history of Axq Capital, LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 11,027 shares of INVA stock, worth $245,350. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,027

Holding current value

$245,350

% of portfolio

0.08%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 10, 2025	BUY	$18.17 - $20.92 $200,360 - $230,684	11,027 New	11,027 $201 Million
Q1 2025 May 13, 2025	BUY	$17.21 - $18.98 $311,466 - $343,500	18,098 New	18,098 $328 Million

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

Black Rock Inc. New York, NY

9.63M
Shares

$214 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.1M
Shares

$158 Million
0.0% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$140 Million
0.14% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.59M
Shares

$102 Million
0.12% of portfolio
Dimensional Fund Advisors LP Austin, TX

4.33M
Shares

$96.4 Million
0.02% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Account